The clinical value of the patient-reported multiple sclerosis neuropsychological screening questionnaire.
Mult Scler
; 25(11): 1543-1546, 2019 10.
Article
em En
| MEDLINE
| ID: mdl-29775164
ABSTRACT
BACKGROUND:
Cognitive problems are difficult to identify in patients with multiple sclerosis (MS).OBJECTIVE:
To investigate the clinical applicability of the patient-reported MS Neuropsychological Screening Questionnaire (MSNQ-P).METHODS:
Cut-off scores were determined to differentiate between cognitively impaired (n = 90), mildly cognitively impaired (n = 115), and cognitively preserved (n = 147) MS patients using receiver operating characteristic analyses.RESULTS:
We could not define specific and sensitive cut-off scores. Higher scores (≥27) did indicate cognitive impairment. Among patients with a higher education, lower scores (<12) indicated intact cognition.CONCLUSION:
Certain scores can indicate intact or impaired cognitive function. Still, MSNQ-P scores should be interpreted with caution.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Autoavaliação Diagnóstica
/
Disfunção Cognitiva
/
Esclerose Múltipla
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
/
Qualitative_research
/
Screening_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Mult Scler
Assunto da revista:
NEUROLOGIA
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
Holanda